期刊文献+

前列腺癌标志物PCA3的研究进展 被引量:7

下载PDF
导出
摘要 前列腺癌是男性泌尿生殖系统常见的恶性肿瘤,患者多数无明显临床症状,常在直肠指检时偶然发现,也可在前列腺增生手术标本中发现。早期诊断、及时治疗是提高前列腺癌患者疗效的重要措施。但目前对前列腺癌的早期筛查仍停留在检测血清前列腺特异性抗原(PSA)水平上,而PSA对于前列腺癌诊断的特异性不高,存在一定局限性。近年研究发现,前列腺癌抗原基因3(PCA3)可能为前列腺癌的特异性标志物。本文就该领域的前沿进展做一小结。
出处 《现代泌尿外科杂志》 CAS 2014年第10期698-702,共5页 Journal of Modern Urology
基金 陕西省自然科学基础研究计划项目(No.19100069)
  • 相关文献

参考文献35

  • 1SIEGELR,NAISHADHAM D,JEMAL A.Cancer statistics,2013[J].CACancerJ Clin,2013,63(1):11-30. 被引量:1
  • 2BAADE PD,YOULDEN DR,CRAMB SM,et al.Epidemiology of prostate cancer in the Asia-Pacific region[J].Prostate Int,2013,1(2):47-58. 被引量:1
  • 3CARTER HB.American Urological Association (AUA) guideline on prostate cancer detection:process and rationale[J].BJU Int,2013,112(5):543-547. 被引量:1
  • 4CRAWFORD ED,BENNETT CL,ANDRIOLE GL,et al.The utility of prostate specific antigen in the management of advanced prostate cancer[J].BJU Int,2013,112(5):548-560. 被引量:1
  • 5CARY KC,COOPERBERG MR.Biomarkers in prostate cancer surveillance and screening:past,present,and future[J].Ther Adv Urol,2013,5(6):318-329. 被引量:1
  • 6BUSSEMAKERS M J,VAN BOKHOVEN A,VERHAEGH GW,et al.DD3:a new prostate specific gene highly overexpressed in prostate cancer[J].Cancer Res,1999,59(23):5975-5979. 被引量:1
  • 7HESSELS D,KLEIN GUNNEWIEK JM,VAN OORT I,et al.DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer[J].Eur Urol,2003,44(1):8-15. 被引量:1
  • 8赵旭兰,傅龙龙,习海波,王共先,冯亮,孙翔,刘伟鹏,张成.外周血中PCA3基因表达及其在前列腺癌诊断中的意义[J].江西医药,2013,48(7):578-581. 被引量:7
  • 9GROSKOPF J,AUBIN SM,DERAS IL,et al.APTIMA PCA3 molecular urine test:development of a method to aid in the diagnosis of prostate cancer[J].Clin Chem,2006,52(6):1089-1095. 被引量:1
  • 10DERAS IL,AUBIN SM,BLASE A,et al.PCA3:a molecular urine assay for predicting prostate biopsy outcome[J].J Urol,2008,179(4):1587-1592. 被引量:1

二级参考文献25

共引文献8

同被引文献113

  • 1吴琪俊,徐剑锋,施榕.前列腺癌易感基因及遗传流行病学研究进展[J].上海交通大学学报(医学版),2011,31(5):672-675. 被引量:10
  • 2李鸣,那彦群.不同水平前列腺特异抗原的前列腺癌诊断率[J].中华医学杂志,2008,88(1):16-18. 被引量:56
  • 3WACHTEL MS, NELIUS T, HAYNES AL, et al. screening and deaths from prostate cancer after diagnosis PSA - a populationbased analysis[J~. Prostate, 2013,73(12): 1365 1369. 被引量:1
  • 4BHINDI B, MAMDANI M, KULKARNI GS, et al. Impact of the U. S. preventive services task {orce recommendations against prostate specific antigen screening on prostate biopsy and cancerdetection rates[J]. J Urol,2015,193(5) ..1519-1524. 被引量:1
  • 5LEYTEN GH, HESSELS D, JANNINK SA, et al. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fu- sions as diagnostic and prognostic urinary biomarkers for pros- tate cancer[J]. Eur Urol,2014,65(3):534-542. 被引量:1
  • 6KARIMI Z, KARIMI L, SHOKROLLAHI H. Nano-magnetic particles used in biomedicine: core and coating materials['J']. Mater Sci Eng C Mater Biol Appl,2013,33(5): 2465-2475. 被引量:1
  • 7BORLIDO L, AZEVEDO AM, ROQUE AC, et al. Magnetic separations in biotechnologyEJ~. Biotechnol Adv, 2013,31 (8) : 1374-1385. 被引量:1
  • 8TOMLINS SA. Urine PCA3 and TMPRSS2:ERG using cancer- specific markers to detect cancer[J]. Eur Urol, 2014,65 (3) : 543- 545. 被引量:1
  • 9ZHANG W, REN SC, SHI XL, et al. A novel urinary long non-coding RNA transcript improves diagnostic accuracy in pa- tients undergoing prostate biopsy [JT. Prostate, 2015,75 (6) : 653-661. 被引量:1
  • 10KELLY BD, MILLER N, HEALY NA, et al. A review of ex- pression profiling of circulating microRNAs in men with prostate caneer[J]. BJU Int,2013,111(1) :17-21. 被引量:1

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部